< Back to companies

Xgenera is a healthcare startup focused on early cancer detection. They have developed a multi-cancer early diagnostic test called miONCO, which is designed to identify cancer accurately at its earliest stages. The test boasts a 99% sensitivity and specificity across all cancer stages while being cost-effective. Xgenera is dedicated to increasing survival rates by enabling earlier diagnosis of cancer, which can significantly improve the chances of successful treatment and recovery. Their innovative approach reflects their commitment to revolutionizing cancer detection and providing people with the best opportunity for early intervention.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2023
Website
www.xgenera.com/

Categories

DiagnosticsCancerScreening & Early DetectionPrecision Medicine/Diagnostics

Disease Areas

Technologies

Diagnostic TestingScreening TechnologyDiagnostics
Only accessible to MedStartr community members. Join now

What do you think of Xgenera?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now